RIO DE JANEIRO, BRAZIL - NotreDame Intermédica (GNDI3) on Monday, June 7, notified the market that it had completed the purchase of the entire stock of Centro Clínico Gaúcho (CCG) on June 4, in a transaction worth "R$1.06 billion (US$211 million), paid in cash, net indebtedness discounted and a portion retained for contingencies."
Centro Clínico Gaúcho has its own network that includes 175,000 beneficiaries, 20 clinical centers, 13 clinical tests units and the Humaniza Hospital. Last year, its consolidated net revenue reached R$371 million.
According to NotreDame, considering synergies, the implied . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here